# CINQAIR
> **BLA761033** · Biologics License Application · Sponsor: TEVA RESPIRATORY LLC · Approved 2016-03-23
## Drug
- **FDA Application Number:** BLA761033
- **Application type:** Biologics License Application
- **Brand name:** CINQAIR
- **Generic name:** RESLIZUMAB
- **Active ingredients:** RESLIZUMAB
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** TEVA RESPIRATORY LLC
- **Manufacturer:** Teva Respiratory, LLC
- **First approval:** 2016-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761033)
---
*MORVS · CC0 1.0*